Researchers at Helen DeVos Children's Hospital in Grand Rapids, Mich., said a clinical trial that included 10 ulcerative colitis patients, ages 7 to 20, showed
fecal microbial transplantation led to a reduction in symptoms within a week for 78% of participants and elimination of symptoms in 33%. The trial, the first in the U.S. to evaluate fecal transplants in children, did not uncover any serious side effects from the procedure.

Full Story:
HealthDay News

Related Summaries